Chengxiang Wang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Ultra High Performance Liquid Chromatography

Pseudomonas Aeruginosa

Breast Cancer Cells

Top Venues

BioMed research international

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Guochao Chen, Wanqiao Zhang, Lingbo Kong, Chengxiang Wang, Xiaojing Lai, Xue Yu, Yuying Guo, Jun Wu, Qun Ma
Qiguiyin Decoction Improves Multidrug-Resistant Pseudomonas aeruginosa Infection in Rats by Regulating Inflammatory Cytokines and the TLR4/MyD88/NF- κ B Signaling Pathway. BioMed research international 2022 (2022)
Nankun Qin, Yue Jiang, Wenjun Shi, Liting Wang, Lingbo Kong, Chengxiang Wang, Yuying Guo, Jiayu Zhang, Qun Ma
High-Throughput Untargeted Serum Metabolomics Analysis of Hyperuricemia Patients by UPLC-Q-TOF/MS. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Guijuan Yue, Chengxiang Wang, Bo Liu, Mangang Wu, Yuangyuan Huang, Yuying Guo
Liposomes co-delivery system of doxorubicin and astragaloside IV co-modified by folate ligand and octa-arginine polypeptide for anti-breast cancer. RSC advances 10 (20) (2020)